Hatteras Investment Partners
Overview
Hatteras Investment Partners is a Raleigh-based alternative investment boutique that historically managed a range of hedge funds and private equity funds before selling its fund assets to The Beneficient Company in 2021.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Kollective Technology | May 2016 | Series C | Co-investor |
| CREATE Medicines | May 2023 | Series A Extension | Lead |
Key People
David B. Perkins
Chief Executive Officer, Co-Founder
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Hatteras Investment Partners based?
Hatteras Investment Partners is headquartered in Raleigh, North Carolina, United States.
When was Hatteras Investment Partners founded?
Hatteras Investment Partners was founded in 2003.
How many portfolio companies does Hatteras Investment Partners have?
Hatteras Investment Partners has 2 portfolio companies in Caplight's dataset.
What are some companies in Hatteras Investment Partners's portfolio?
Portfolio companies visible on Caplight include Kollective Technology, CREATE Medicines.
What was Hatteras Investment Partners's most recent investment shown here?
Hatteras Investment Partners's most recent investment in this portfolio sample was in CREATE Medicines in 2023.
What sectors does Hatteras Investment Partners focus on?
Hatteras Investment Partners focuses on Healthcare & Life Sciences, Enterprise Software, Telecommunications & Networking.
What company stages does Hatteras Investment Partners focus on?
Stage focus information for Hatteras Investment Partners is not publicly available.
What is Hatteras Investment Partners's AUM?
Hatteras Investment Partners's assets under management are estimated between $114.8M and $114.8M.